The president of Cuba, Miguel Diaz-Canel, praised the country’s progress in immunizing the population against Covid-19 with the use of vaccine candidates produced by the national biotechnology industry.
With the highest rate of patients recovered from COVID-19 in the Americas -94.2% as of March 20 - and two candidate vaccines in the final stage of clinical trials, Cuba is consolidating its national strategy to confront the pandemic, with results recently recognized by Bolivia’s President Luis Arce.
By mid-year, 70 percent of the Cuban population will be immunized against the SARS-Cov-2 virus as part of a vaccination strategy by population groups, scientists and health authorities explained Tuesday.
A group of measures to contribute to the control of COVID-19 and curb the wide spread of the disease in the province of Holguín will come into force as of today, with the aim of reducing the incidence of the disease in the eastern territory.
Cuba begins on Monday vaccinating against anti-Covid-19 all its health sector, from doctors, nurses, technical and support staff with Sovereign 2 vaccine as part of Phase III trials in all of Havana medical institutions.